Back to Market Feed

Product Information

NEOMYC-POLYM-DEXAMET EYE OINTM is a generic product labeled by Bausch & Lomb Incorporated, priced at $2.6872 per GM under NDC 24208079535. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 25, 1994. Its Orange Book therapeutic-equivalence code is AT.

NEOMYC-POLYM-DEXAMET EYE OINTM

Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone
$2.6872per GM

Strength

1; 3.5; 10000 mg/g; mg/g; [USP'U]/g

NDC

24208079535

Classification

Generic

Dosage Form

OINTMENT

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA064063

FDA Approved

7/25/1994

TE Code

AT

On Market Since

7/25/1994

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polymyxin-class Antibacterial
Polymyxins

Price Statistics

The NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 38.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6872 per GM
All-time high$4.8575 (Oct 15, 2014)
All-time low$2.1009 (Nov 20, 2024)
52-week high$2.9358
52-week low$2.6623
Median price$3.2785
Average price$3.4420
Largest weekly change+38.7% (Oct 23, 2019)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-1.0%

1M

-1.0%

3M

-2.6%

6M

+0.9%

1Y

-5.0%

3Y

-17.5%

5Y

-13.0%

All

-38.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TRIAMCINOLONE 0.1% CREAM
Generic
00168000416•E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
$0.0247
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
16714098604•NorthStar Rx LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
21922006230•Encube Ethicals, Inc.
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
33342032954•Macleods Pharmaceuticals Limited
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
45802006405•Padagis Israel Pharmaceuticals Ltd
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
52817081154•TruPharma LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
67877025145•Ascend Laboratories, LLC
$0.0280
per GM
DEXAMETHASONE 0.5 MG/5 ML LIQ
Generic
00054317763•Hikma Pharmaceuticals USA Inc.
$0.0293
per ML
TRIAMCINOLONE 0.1% CREAM
Generic
68462013159•Glenmark Pharmaceuticals Inc., USA
$0.0300
per GM
TRIAMCINOLONE 0.1% OINTMENT
Generic
16714027603•NorthStar Rx LLC
$0.0348
per GM

Frequently asked questions

What is the NADAC price of NEOMYC-POLYM-DEXAMET EYE OINTM?

The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-POLYM-DEXAMET EYE OINTM, manufactured by Bausch & Lomb Incorporated, is $2.6872 per GM (NDC 24208079535), effective Aug 19, 2026.

How has the price of NEOMYC-POLYM-DEXAMET EYE OINTM changed over time?

Over the history we have for it, the NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has declined 38.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEOMYC-POLYM-DEXAMET EYE OINTM?

Since Nov 28, 2013, the NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has ranged from a low of $2.1009 (Nov 20, 2024) to a high of $4.8575 (Oct 15, 2014), with a median of $3.2785 per GM.

Are there cheaper alternatives to NEOMYC-POLYM-DEXAMET EYE OINTM?

No other NADAC-published product currently shares the active ingredient and strength of NEOMYC-POLYM-DEXAMET EYE OINTM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NEOMYC-POLYM-DEXAMET EYE OINTM?

NEOMYC-POLYM-DEXAMET EYE OINTM (NDC 24208079535) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.